Literature DB >> 22138638

Thioredoxin 1 is responsible for antibody disulfide reduction in CHO cell culture.

Kristen L Koterba1, Trissa Borgschulte, Michael W Laird.   

Abstract

During large-scale manufacturing of an IgG1 monoclonal antibody in Chinese hamster ovary (CHO) cells, reduction of the antibody's disulfide bonds was observed. We present evidence that mammalian thioredoxin 1 (TXN1) is the terminal enzyme responsible for this reduction event. We demonstrate a marked prevention of IgG1 disulfide bond reduction in a cell-density dependent manner by knocking down expression of TXN1 via lentivirus transduction of short hairpin RNA.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138638     DOI: 10.1016/j.jbiotec.2011.11.009

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  17 in total

1.  Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.

Authors:  Katariina M Hutterer; Robert W Hong; Jonathon Lull; Xiaoyang Zhao; Tian Wang; Rex Pei; M Eleanor Le; Oleg Borisov; Rob Piper; Yaoqing Diana Liu; Krista Petty; Izydor Apostol; Gregory C Flynn
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

Review 2.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

3.  Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process.

Authors:  Cheng Du; Yunping Huang; Ameya Borwankar; Zhijun Tan; Anthony Cura; Joon Chong Yee; Nripen Singh; Richard Ludwig; Michael Borys; Sanchayita Ghose; Nesredin Mussa; Zheng Jian Li
Journal:  MAbs       Date:  2018-01-23       Impact factor: 5.857

Review 4.  Micro-Heterogeneity of Antibody Molecules.

Authors:  Yusuke Mimura; Radka Saldova; Yuka Mimura-Kimura; Pauline M Rudd; Roy Jefferis
Journal:  Exp Suppl       Date:  2021

5.  Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.

Authors:  Yaoxing Huang; Jian Yu; Anastasia Lanzi; Xin Yao; Chasity D Andrews; Lily Tsai; Mili R Gajjar; Ming Sun; Michael S Seaman; Neal N Padte; David D Ho
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

Review 6.  Assessment of disulfide and hinge modifications in monoclonal antibodies.

Authors:  Bernd Moritz; Jan Olaf Stracke
Journal:  Electrophoresis       Date:  2017-03-02       Impact factor: 3.535

7.  Effects of diluents on cell culture viability measured by automated cell counter.

Authors:  Aaron Chen; Matthew Leith; Roger Tu; Gurpreet Tahim; Anish Sudra; Swapnil Bhargava
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

8.  Optimization and kinetic modeling of interchain disulfide bond reoxidation of monoclonal antibodies in bioprocesses.

Authors:  Peifeng Tang; Zhijun Tan; Vivekh Ehamparanathan; Tingwei Ren; Laurel Hoffman; Cheng Du; Yuanli Song; Li Tao; Angela Lewandowski; Sanchayita Ghose; Zheng Jian Li; Shijie Liu
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

Review 9.  Posttranslational Modifications and the Immunogenicity of Biotherapeutics.

Authors:  Roy Jefferis
Journal:  J Immunol Res       Date:  2016-04-14       Impact factor: 4.818

10.  Quantitative definition and monitoring of the host cell protein proteome using iTRAQ - a study of an industrial mAb producing CHO-S cell line.

Authors:  Lesley M Chiverton; Caroline Evans; Jagroop Pandhal; Andrew R Landels; Byron J Rees; Peter R Levison; Phillip C Wright; C Mark Smales
Journal:  Biotechnol J       Date:  2016-06-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.